• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疾病相关 TERT 变体的改变核苷酸插入机制。

Altered Nucleotide Insertion Mechanisms of Disease-Associated TERT Variants.

机构信息

Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS 66103, USA.

University of Kansas Cancer Center, Kansas City, KS 66103, USA.

出版信息

Genes (Basel). 2023 Jan 21;14(2):281. doi: 10.3390/genes14020281.

DOI:10.3390/genes14020281
PMID:36833208
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9957172/
Abstract

Telomere biology disorders (TBDs) are a spectrum of diseases that arise from mutations in genes responsible for maintaining telomere integrity. Human telomerase reverse transcriptase (hTERT) adds nucleotides to chromosome ends and is frequently mutated in individuals with TBDs. Previous studies have provided insight into how relative changes in hTERT activity can lead to pathological outcomes. However, the underlying mechanisms describing how disease-associated variants alter the physicochemical steps of nucleotide insertion remain poorly understood. To address this, we applied single-turnover kinetics and computer simulations to the TERT (tcTERT) model system and characterized the nucleotide insertion mechanisms of six disease-associated variants. Each variant had distinct consequences on tcTERT's nucleotide insertion mechanism, including changes in nucleotide binding affinity, rates of catalysis, or ribonucleotide selectivity. Our computer simulations provide insight into how each variant disrupts active site organization, such as suboptimal positioning of active site residues, destabilization of the DNA 3' terminus, or changes in nucleotide sugar pucker. Collectively, this work provides a holistic characterization of the nucleotide insertion mechanisms for multiple disease-associated TERT variants and identifies additional functions of key active site residues during nucleotide insertion.

摘要

端粒生物学疾病(TBDs)是一组由负责维持端粒完整性的基因发生突变而引起的疾病。人端粒酶逆转录酶(hTERT)在染色体末端添加核苷酸,并且在 TBD 患者中经常发生突变。先前的研究提供了关于 hTERT 活性的相对变化如何导致病理结果的深入了解。然而,描述疾病相关变异如何改变核苷酸插入的物理化学步骤的潜在机制仍知之甚少。为了解决这个问题,我们将单轮动力学和计算机模拟应用于 TERT(tcTERT)模型系统,并对六种疾病相关变体的核苷酸插入机制进行了表征。每个变体对 tcTERT 的核苷酸插入机制都有独特的影响,包括核苷酸结合亲和力、催化速率或核糖核苷酸选择性的变化。我们的计算机模拟提供了对每个变体如何破坏活性位点组织的深入了解,例如活性位点残基的位置不合适、DNA 3'末端的不稳定或核苷酸糖的构象变化。总的来说,这项工作对多种疾病相关的 TERT 变体的核苷酸插入机制进行了全面的描述,并确定了在核苷酸插入过程中关键活性位点残基的额外功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17e/9957172/516f7490ff84/genes-14-00281-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17e/9957172/66f33f98b2a3/genes-14-00281-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17e/9957172/4ab322b70024/genes-14-00281-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17e/9957172/536fd73479ef/genes-14-00281-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17e/9957172/f323ad36eab9/genes-14-00281-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17e/9957172/516f7490ff84/genes-14-00281-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17e/9957172/66f33f98b2a3/genes-14-00281-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17e/9957172/4ab322b70024/genes-14-00281-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17e/9957172/536fd73479ef/genes-14-00281-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17e/9957172/f323ad36eab9/genes-14-00281-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c17e/9957172/516f7490ff84/genes-14-00281-g005.jpg

相似文献

1
Altered Nucleotide Insertion Mechanisms of Disease-Associated TERT Variants.疾病相关 TERT 变体的改变核苷酸插入机制。
Genes (Basel). 2023 Jan 21;14(2):281. doi: 10.3390/genes14020281.
2
Mechanisms of nucleotide selection by telomerase.端粒酶核苷酸选择的机制。
Elife. 2020 Jun 5;9:e55438. doi: 10.7554/eLife.55438.
3
Human telomerase reverse transcriptase (hTERT) Q169 is essential for telomerase function in vitro and in vivo.人类端粒酶逆转录酶 (hTERT) Q169 对于端粒酶在体外和体内的功能至关重要。
PLoS One. 2009 Sep 24;4(9):e7176. doi: 10.1371/journal.pone.0007176.
4
Functional interaction between compound heterozygous TERT mutations causes severe telomere biology disorder.复合杂合 TERT 突变的功能相互作用导致严重的端粒生物学紊乱。
Blood Adv. 2022 Jun 28;6(12):3779-3791. doi: 10.1182/bloodadvances.2022007029.
5
An intact putative mouse telomerase essential N-terminal domain is necessary for proper telomere maintenance.完整的假定小鼠端粒酶必需N端结构域对于端粒的正常维持是必要的。
Biol Cell. 2016 Apr;108(4):96-112. doi: 10.1111/boc.201500089. Epub 2016 Feb 18.
6
Characterization of novel mutations in the TEL-patch domain of the telomeric factor TPP1 associated with telomere biology disorders.鉴定与端粒生物学疾病相关的端粒因子 TPP1 的 TEL-patch 结构域中的新型突变。
Hum Mol Genet. 2024 Mar 20;33(7):612-623. doi: 10.1093/hmg/ddad210.
7
The Insertion in Fingers Domain in Human Telomerase Can Mediate Enzyme Processivity and Telomerase Recruitment to Telomeres in a TPP1-Dependent Manner.人类端粒酶中的手指插入结构域可通过依赖TPP1的方式介导酶的持续合成能力以及端粒酶向端粒的募集。
Mol Cell Biol. 2015 Oct 26;36(1):210-22. doi: 10.1128/MCB.00746-15. Print 2016 Jan 1.
8
An anchor site-type defect in human telomerase that disrupts telomere length maintenance and cellular immortalization.人类端粒酶中一种锚定位点型缺陷,该缺陷会破坏端粒长度维持和细胞永生化。
Mol Biol Cell. 2005 Jul;16(7):3152-61. doi: 10.1091/mbc.e05-02-0148. Epub 2005 Apr 27.
9
The C terminus of the human telomerase reverse transcriptase is a determinant of enzyme processivity.人端粒酶逆转录酶的C末端是酶持续合成能力的决定因素。
Nucleic Acids Res. 2003 Jul 15;31(14):4059-70. doi: 10.1093/nar/gkg437.
10
hTERT mutations associated with idiopathic pulmonary fibrosis affect telomerase activity, telomere length, and cell growth by distinct mechanisms.与特发性肺纤维化相关的 hTERT 突变通过不同的机制影响端粒酶活性、端粒长度和细胞生长。
Aging Cell. 2012 Jun;11(3):482-90. doi: 10.1111/j.1474-9726.2012.00810.x. Epub 2012 Mar 19.

引用本文的文献

1
hTERT gene methylation in circulating DNA, tumor, and surrounding tissue in breast cancer: a prospective study.循环 DNA、肿瘤和乳腺癌周围组织中 hTERT 基因甲基化:一项前瞻性研究。
Sao Paulo Med J. 2024 May 10;142(5):e2023140. doi: 10.1590/1516-3180.2023.0140.R1.04032024. eCollection 2024.
2
Special Issue "DNA Replication/Repair, and the DNA Damage Response in Human Disease".特刊征稿:“人类疾病中的 DNA 复制/修复和 DNA 损伤反应”
Genes (Basel). 2023 Apr 11;14(4):893. doi: 10.3390/genes14040893.

本文引用的文献

1
Structure of active human telomerase with telomere shelterin protein TPP1.活性人端粒酶与端粒保护蛋白 TPP1 的结构。
Nature. 2022 Apr;604(7906):578-583. doi: 10.1038/s41586-022-04582-8. Epub 2022 Apr 13.
2
Structural basis of human telomerase recruitment by TPP1-POT1.人端粒酶通过 TPP1-POT1 招募的结构基础。
Science. 2022 Mar 11;375(6585):1173-1176. doi: 10.1126/science.abn6840. Epub 2022 Feb 24.
3
Flexibility of telomerase in binding the RNA template and DNA telomeric repeat.端粒酶结合 RNA 模板和 DNA 端粒重复序列的灵活性。
Proc Natl Acad Sci U S A. 2022 Jan 4;119(1). doi: 10.1073/pnas.2116159118.
4
The Processivity of Telomerase: Insights from Kinetic Simulations and Analyses.端粒酶的延伸能力:来自动力学模拟和分析的见解。
Molecules. 2021 Dec 13;26(24):7532. doi: 10.3390/molecules26247532.
5
Zipper head mechanism of telomere synthesis by human telomerase.端粒酶催化的人端粒合成的拉链头机制。
Cell Res. 2021 Dec;31(12):1275-1290. doi: 10.1038/s41422-021-00586-7. Epub 2021 Nov 15.
6
Altered APE1 activity on abasic ribonucleotides is mediated by changes in the nucleoside sugar pucker.无碱基核糖核苷酸上APEX1活性的改变是由核苷糖构象的变化介导的。
Comput Struct Biotechnol J. 2021 May 25;19:3293-3302. doi: 10.1016/j.csbj.2021.05.035. eCollection 2021.
7
Structures of telomerase at several steps of telomere repeat synthesis.端粒酶在端粒重复合成的几个步骤中的结构。
Nature. 2021 May;593(7859):454-459. doi: 10.1038/s41586-021-03529-9. Epub 2021 May 12.
8
Alternative splicing regulates telomerase repression.可变剪接调控端粒酶抑制。
Nat Rev Genet. 2021 Jul;22(7):414. doi: 10.1038/s41576-021-00372-6.
9
Structure of human telomerase holoenzyme with bound telomeric DNA.人端粒酶全酶与结合的端粒 DNA 的结构。
Nature. 2021 May;593(7859):449-453. doi: 10.1038/s41586-021-03415-4. Epub 2021 Apr 21.
10
Molecular mechanisms of telomere biology disorders.端粒生物学紊乱的分子机制。
J Biol Chem. 2021 Jan-Jun;296:100064. doi: 10.1074/jbc.REV120.014017. Epub 2020 Nov 22.